搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按相关度排序
按时间排序
2 小时
on MSN
Eli Lilly (LLY): Revenue Boost from Zepbound and Mounjaro Amid Strong Market Projections
We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to take a look at where Eli ...
3 天
on MSN
Eli Lilly’s Zepbound to undergo first-of-its-kind study on economic impact
Eli Lilly (LLY) partners with British government for a first-of-its-kind real-world study on economic effects of its weight ...
1 天
on MSN
This is Huge News For Eli Lilly Investors
Lilly has been solidly investing in research and development (R&D) throughout 2024. In April, the company announced the ...
2 天
on MSN
Should Eli Lilly Investors Worry About This Unexpected FDA Move?
Eli Lilly (NYSE: LLY) sells treatments for a wide variety of therapeutic areas, but one portfolio in particular has driven ...
2 天
3 Reasons Eli Lilly Stock Isn't Going to Run out of Steam Anytime Soon
Eli Lilly's valuation could look much more modest in the future, as its earnings should continue to grow at a high rate.
3 小时
Why Eli Lilly Stock Is Soaring—And How It Plans To Stay On Top
In a year and a half, Eli Lilly (NYSE: LLY) has roughly doubled in value. It is now the most valuable pharmaceutical company in the world.
来自MSN
1 天
Lilly Loses Around $14B This Week: How to Play LLY Stock
The stock of Eli Lilly and Company LLY has declined 1.7% already this week, losing almost $14 billion of its market value.
6 天
Eli Lilly Expects Zepbound Approval in Japan by Mid-2025, Eyes Weight-Loss Market
Eli Lilly anticipates regulatory approval for its weight-loss drug Zepbound in Japan by mid-2025, boosting its global ...
FiercePharma
7 小时
Lilly joins OAC campaign against obesity stigma, partnering on gallery of bias-free images ...
Since 2021, the Obesity Action Coalition (OAC) has led a national public awareness campaign against weight bias with a goal ...
7 小时
Investigating Eli Lilly's Standing In Pharmaceuticals Industry Compared To Competitors
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and ...
2 天
on MSN
Can weight-loss drug help employment? This is how obesity drug Zepbound maker Eli Lilly can ...
In a bid to combat obesity and unemployment, the UK govt is collaborating with Eli Lilly, which will invest £279 mn in a ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈